AstraZeneca PLC (LON:AZN) Receives 'Hold' Rating From Brokers At Shore Capital

Ivan Schwartz
May 22, 2017

The Company, through its subsidiary, United Utilities Water Limited (United Utilities Water), manages the regulated water and wastewater network in the North West of England, providing services to around seven million people and businesses. It has a 2.32 P/E ratio. Gypsum wallboard is a primary building material used in residential and commercial construction and in fix and remodel. Peel Hunt's price objective indicates a potential upside of 16.85% from the stock's current price.

Among 15 analysts covering EnQuest Plc (LON:ENQ), 4 have Buy rating, 4 Sell and 7 Hold. 1 funds opened positions while 0 raised stakes.

Ratings analysis reveals 70% of CRH Plc.'s analysts are positive. The rating was maintained by Panmure Gordon on Friday, July 31 with "Sell".

About 226,572 shares traded or 576.94% up from the average. On Tuesday, September 1 the stock rating was maintained by Numis Securities with "Add". The rating was maintained by Barclays Capital with "Equal Weight" on Wednesday, August 24. Northland Capital maintained the stock with "Outperform" rating in Tuesday, November 10 report. The rating was maintained by BNP Paribas with "Neutral" on Monday, July 27.

ILLEGAL ACTIVITY WARNING: "Liberum Capital Raises Bodycote PLC (BOY) Price Target to GBX 910" was posted by BBNS and is the sole property of of BBNS. Canaccord Genuity downgraded the shares of ENQ in report on Friday, September 11 to "Hold" rating.

The stock increased 0.91% or GBX 5.1 on May 17, reaching GBX 567.6. Barclays PLC (LON:BARC) has risen 6.00% since April 17, 2017 and is uptrending. It has by 0.00% the S&P500. O'Brien Shelly had sold 4,500 shares worth $175,350.

Trump pulls trigger for NAFTA talks
Lighthizer noted the deal has been a success for some USA industries, such as agriculture, investment services and energy. Lighthizer said he did not think a new threat to withdraw from NAFTA would be necessary.

Huntsman, Clariant in Talks to Merge
Huntsman had a market value of $6.4 billion while Clariant's was 6.9 billion Swiss francs ($7.1 billion). The transaction, previously reported by Reuters, is targeted to close by the end of the year.

Silva service at Hull to be decided at Wednesday meeting
They are happy here, we have an exciting project. "It is a good platform for us to next season to improve and try to win". Click through the gallery above to see the final top 10 Premier League goalscorers for the 2016/17 season.

Investors sentiment decreased to 0.98 in 2016 Q4. The Kentucky-based Todd Asset Management Llc has invested 0.47% in the stock.

Centrica plc is an energy and services company. The stock's market cap is GBX 4.31 billion. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Shareholders of record on Thursday, May 18th will be paid a dividend of GBX 37.50 ($0.48) per share. The stock of Centrica PLC (LON:CNA) earned "Hold" rating by Deutsche Bank on Friday, February 19. Therefore 100% are positive. Aviva plc has a one year low of GBX 290.00 and a one year high of GBX 570.50. They now have a GBX 1,900 ($24.53) price objective on the stock. John Wood Group plc had 3 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned "Buy" rating on Tuesday, February 28 by Shore Capital. Numis Securities maintained BTG plc (LON:BTG) on Thursday, October 6 with "Hold" rating. Deutsche Bank maintained the stock with "Buy" rating in Wednesday, March 2 report.

21/10/2016 - London Stock Exchange Group had its "Outperform" rating reiterated by analysts at Exane BNP Paribas. Credit Suisse Group AG restated an outperform rating and set a GBX 1,300 ($16.78) price objective on shares of IMI plc in a research report on Thursday, March 30th.

Among 11 analysts covering BTG PLC (LON:BTG), 8 have Buy rating, 0 Sell and 3 Hold.

Receive AstraZeneca PLC News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca PLC with's FREE daily email newsletter.

Other reports by GizPress

Discuss This Article